Key Developments: Greatbatch Inc (GB)

GB on New York Consolidated

46.30USD
23 Oct 2014
Price Change (% chg)

$0.22 (+0.48%)
Prev Close
$46.08
Open
$46.42
Day's High
$47.09
Day's Low
$46.19
Volume
82,875
Avg. Vol
153,680
52-wk High
$51.64
52-wk Low
$35.73

Search Stocks

Latest Key Developments (Source: Significant Developments)

Greatbatch Inc acquires CCC Medical Devices
Tuesday, 12 Aug 2014 02:11pm EDT 

Greatbatch Inc:Announced that it has acquired CCC Medical Devices (CCC), globally-respected active implantable medical device (AIMD) systems developer and manufacturer.Acquisition effective immediately.Based in Montevideo, Uruguay, CCC designs and produces range of devices for some of world's top medical device companies, including implantable pulse generators, programmer systems, battery chargers, patient wands and leads.  Full Article

Greatbatch Inc reaffirms FY 2014 guidance
Thursday, 31 Jul 2014 04:17pm EDT 

Greatbatch Inc:Confirms FY 2014 revenue and adjusted diluted EPS guidance provided at the beginning of year.Expects FY 2014 sales in the range of $685 - $705 million.Expects FY 2014 GAAP Diluted EPS in the range of $1.94 - $1.99.Expects FY 2014 Adjusted Diluted EPS in the range of $2.25 - $2.35.FY 2014 revenue of $705 million and EPS of $2.33 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc sees FY 2014 guidance at upper end of prior range
Wednesday, 30 Apr 2014 04:05pm EDT 

Greatbatch Inc:Expects FY 2014 guidance at the upper end of 3pct to 6pct organic constant currency revenue growth and 7pct to 12pct adjusted diluted EPS improvement.Reported revenue of $663.9 million and EPS of $2.10 in FY 2013.FY 2014 revenue of $694.6 million and EPS of $2.32 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc reaffirms FY 2014 guidance
Monday, 24 Feb 2014 04:20pm EST 

Greatbatch Inc:Confirms FY 2014 guidance of 3 to 6 percentage organic constant currency revenue growth and 7 to 12 percentage adjusted diluted EPS improvement.The company reported revenue of $663.9 million and EPS of $2.10 in FY 2013.FY 2014 revenue of $690 million and EPS of $2.31 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc Sees FY 2013 Revenue Guidance At Lower End Of Prior Range; Sees FY 2013 EPS Guidance At Mid-Point Or Better Prior Range
Thursday, 24 Oct 2013 04:05pm EDT 

Greatbatch Inc announced that based upon its results for the first three quarters, as well as the Company's expectations for the remainder of 2013, the Company continue to believe that revenue for fiscal 2013 to be at the lower end of its original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5% - 8% after adjusting for the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. Because of the Company's strong productivity performance and favorable mix of product sales the Company believe that its adjusted diluted EPS will be at the mid-point or better of its previous $2.05 to $2.15 guidance. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $664 million and EPS of $2.09 for fiscal 2013  Full Article

Greatbatch Inc Raises FY 2013 EPS Guidance; Reaffirms FY 2013 Revenue Guidance
Thursday, 25 Jul 2013 04:05pm EDT 

Greatbatch Inc announced that based upon its results for the first half of the year, as well as its expectations for the remainder of 2013, at this time the Company raising its 2013 adjusted diluted EPS guidance ranges to $2.05 to $2.15 per share from the previously communicated $2.00 to $2.05 per share. For fiscal 2013, the Company continue to believe that revenue will be at the lower end of its original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5% - 8% after adjusting for the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.98 and revenue of $661 million for fiscal 2013.  Full Article

Greatbatch Inc's Greatbatch Ltd Files Patent Infringement Complaint Against AVX Corp In Federal Court
Friday, 26 Apr 2013 04:28pm EDT 

Greatbatch Ltd., a wholly owned subsidiary of Greatbatch Inc., announced that it has filed a complaint in the U.S. District Court for the District of Delaware against AVX Corp and AVX Filter Corporation. The complaint alleges that AVX has infringed a Greatbatch patent by manufacturing and selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that incorporate its patented technology. US Patent 5,905,627 was issued to Richard Brendel and Robert Stevenson for an invention entitled Internally Grounded Feedthrough Filter Capacitor. The invention shields and decouples the terminal pins in implantable medical devices to prevent interference from externally generated electromagnetic fields from devices such as mobile phones. Greatbatch took ownership of key patents in this field when the Company acquired Maxwell Electronics Group Inc. of Carson City, Nevada in 2001.  Full Article

Greatbatch Inc Reaffirms FY 2013 Guidance
Thursday, 25 Apr 2013 04:05pm EDT 

Greatbatch Inc reaffirmed adjusted operating income as a percentage of sales and adjusted diluted EPS guidance ranges provided at the beginning of fiscal 2013. The Company expects adjusted operating income as a % of sales 12.0%-12.5%, adjusted Diluted EPS $1.90-$2.00. Based on the actual results for the first quarter and current expectations for the remainder of the year, it sees a general trend towards the lower end of original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5%-8% due to the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $669 million and EPS of $1.95 for fiscal 2013.  Full Article

Greatbatch Inc Reaffirms FY 2013 Guidance
Monday, 18 Mar 2013 04:00pm EDT 

Greatbatch Inc. announced that for fiscal 2013, it expects sales to be between $660 million to $680 million and earnings per share (EPS) to be $1.90 to $2.00 a share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $669 million and EPS of $1.95 for fiscal 2013.  Full Article

Greatbatch Inc Reaffirms FY 2013 Guidance
Monday, 25 Feb 2013 04:05pm EST 

Greatbatch Inc. announced that for fiscal 2013, it expects sales to be between $660 million to $680 million and earnings per share (EPS) to be $1.90 to $2.00 a share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $669 million and EPS of $1.96 for fiscal 2013.  Full Article

Search Stocks